The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE Heart Failure Care network
Martin R Cowie,Ricardo Mourilhe-Rocha,Hung-Yu Chang,Maurizio Volterrani,Ha Ngoc Ban,Denilson Campos de Albuquerque,Edward Chung,Cândida Fonseca,Yuri Lopatin,José Antonio Magaña Serrano,Lilyana Mircheva,Gustavo Adolfo Moncada-Paz,Zurab Pagava,Eugenio B Reyes,Clara Saldarriaga,Pedro Schwartzmann,David Sim Kheng Leng,Marcelo Trivi,Yoto Trifonov Yotov,Shelley Zieroth,OPTIMIZE Heart Failure Care program coordinators
DOI: https://doi.org/10.1016/j.ijcard.2022.06.022
2022-09-15
Abstract:During the COVID-19 pandemic, reductions in heart failure (HF) hospitalizations have been widely reported, and there is an urgent need to understand how HF care has been reorganized in countries with different infection levels, vaccination rates and healthcare services. The OPTIMIZE Heart Failure Care program has a global network of investigators in 42 countries, with first-hand experience of the impact of the pandemic on HF management in different care settings. The national coordinators were surveyed to assess: 1) the challenges of the COVID-19 pandemic for continuity of HF care, from both a hospital and patient perspective; 2) the organizational changes enacted to ensure continued HF care; and 3) lessons learned for the future of HF care. Contributions were obtained from 37 national coordinators in 29 countries. We summarize their input, highlighting the issues raised and using the example of three very different settings (Italy, Brazil, and Taiwan) to illustrate the similarities and differences across the OPTIMIZE program.